The Utility and Feasibility of Mt-sDNA as a Surveillance Procedure in Colorectal Cancer Survivors
NCT04624555 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2026-04-09
Summary
The purpose of this research study is to determine whether testing of stool for a panel of markers will enable us to detect polyps and cancer compared to standard testing.
Conditions
- Adenocarcinoma of the Colon
- Adenocarcinoma of the Rectum
- Stage I Colorectal Cancer
- Stage II Colorectal Cancer
- Stage III Colorectal Cancer
Sponsors & Collaborators
-
Case Comprehensive Cancer Center
lead OTHER
Principal Investigators
-
Gregory Cooper, MD · University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-10-31
- Primary Completion
- 2026-09-01
- Completion
- 2026-09-01
Countries
- United States
Study Locations
More Related Trials
-
Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening "BLUE-C"
NCT04144738 ·Status: COMPLETED
-
Circulating Tumor DNA Methylation Guided Postoperative Follow-up Strategy for Non-metastatic Colorectal Cancer
NCT05904665 ·Status: RECRUITING ·Phase: NA
-
A Multicenter Clinical Trial of Stool-based DNA Testing for Early Detection of Colon Cancer in China
NCT04722055 ·Status: COMPLETED
-
Use of ctDNA for Monitoring of Stage III Colorectal Cancer
NCT02842203 ·Status: ACTIVE_NOT_RECRUITING
-
Point of Care Test to Diagnosed Colorectal Cancer and Polyps in Low Middle Income Countries
NCT03173729 ·Status: COMPLETED
-
Application of FIT-DNA Detection in Following Colorectal Cancer Resection-Implications for Surveillance
NCT05528783 ·Status: RECRUITING
-
The Implication of Plasma ctDNA Methylation Haplotypes in Detecting Colorectal Cancer and Adenomas
NCT03737591 ·Status: COMPLETED
-
Screening Tests in Detecting Colorectal Cancer
NCT00025025 ·Status: COMPLETED
-
Predictive Value of Drug Sensitivity Testing Tumorspheres From Patients With Metastatic Colorectal Cancer
NCT03251612 ·Status: COMPLETED ·Phase: PHASE2
-
Validation of Colon Biomarkers for the Early Detection of Colorectal Adenocarcinoma
NCT01511653 ·Status: COMPLETED
-
A Clinical Study Aims to Assess the Consistency of Clinical Efficacy in Colorectal Cancer Treatment and Drug Susceptibility Outcomes Using a Novel Drug Susceptibility Testing Method
NCT06100016 ·Status: RECRUITING
-
Detection of Colorectal Cancer in Peripheral Blood by Septin 9 DNA Methylation Assay
NCT00696345 ·Status: COMPLETED
-
Stool-based SDC2 DNA Methylation Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
NCT04221854 ·Status: UNKNOWN ·Phase: NA
-
Early Detection of Advanced Adenomas and Colorectal Cancer
NCT06342440 ·Status: RECRUITING
-
Survivorship Care Planning in Patients With Colorectal or Non-Small Cell Lung Cancer
NCT01741636 ·Status: COMPLETED ·Phase: NA
-
Evaluation of a Model for the Early Diagnosis of Colorectal Cancer by the Detection of 5-hydroxymethylcytosine (5-hmC) in Plasma Cell-free DNA to the Community Colorectal Cancer Screening Program
NCT05638243 ·Status: UNKNOWN
-
Blood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast
NCT03789162 ·Status: COMPLETED
-
Fecal DNA Methylation Test for Colorectal Cancer Screening
NCT04823793 ·Status: UNKNOWN
-
A Multi-center Trial to Establish a Model for the Early Diagnosis of Colorectal Cancer by the Detection of 5-hydroxymethylcytosine (5-hmC) in Plasma Cell-free DNA
NCT03676075 ·Status: UNKNOWN
-
Hereditary Nonpolyposis Colorectal Cancer in Taiwan-Related Genetic Study and Clinical Applications
NCT00262171 ·Status: UNKNOWN
-
Application of Hyperspectral Imaging Analysis Technology in the Diagnosis of Colorectal Cancer Based on Colonoscopic Biopsy
NCT05576506 ·Status: COMPLETED
-
Evaluation of a Point-of-care Testing Instrument for Fecal Immunochemical Test
NCT05232721 ·Status: UNKNOWN
-
Next-generation Sequencing of Colorectal Cancer Somatic Cells to Guide Genetic Susceptibility Gene Mutations Screening.
NCT04280666 ·Status: UNKNOWN
-
ctDNA as a Prognostic Marker for Postoperative Relapse in Early and Intermediate Stage Colorectal Cancer
NCT03312374 ·Status: UNKNOWN
-
Diagnostic Accuracy of a Panel of Bacterial Gene Markers (M3) for Colorectal Advanced Neoplasia
NCT05405673 ·Status: RECRUITING